GKSL — Gujarat Kidney and Super Speciality Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Market Cap
IN₹10.19bn
Enterprise Value
IN₹9.91bn
Revenue
IN₹820.13m

Annual income statement for Gujarat Kidney and Super Speciality, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0	47.7	402	820
Cost of Revenue
Gross Profit	0	0	43.9	356	729
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	6.49	0.063	31.4	269	598
Operating Profit	-6.49	-0.063	16.3	133	222
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1.37	-0.062	22.7	128	212
Provision for Income Taxes
Net Income After Taxes	1	-0.062	17.1	95	168
Minority Interest
Net Income Before Extraordinary Items
Net Income	1	-0.062	17.1	94.1	155
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1	-0.062	17.1	94.1	155
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.013	-0.001	0.15	1.19	2.49
Dividends per Share